Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.79 |
| ▸ | NQO2 | P16083 | 7/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.68 |
| ▸ | MEN1 | O00255 | 3/20 | 0.68 |
| ▸ | NPC1 | O15118 | 3/20 | 0.68 |
| ▸ | POLB | P06746 | 2/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.68 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | GLA | P06280 | 2/20 | 0.61 |
| ▸ | ACHE | P22303 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13156546 | 1.00 | MAPT (0.79) | MAPTNQO2KMT2AMEN1NPC1 | |
| SCHEMBL29614768 | 1.00 | MAPT (0.79) | MAPTNQO2KMT2AMEN1NPC1 | |
| SCHEMBL31319857 | 0.91 | NQO2 (0.94) | MAPTNQO2KMT2AMEN1NPC1 | |
| Phenazine SCHEMBL9049 | 0.89 | MAPT (1.00) | MAPTNQO2KMT2AMEN1NPC1 | |
| Phenazine SCHEMBL29356959 | 0.89 | MAPT (1.00) | MAPTNQO2KMT2AMEN1NPC1 | |
| Phenazine SCHEMBL27643128 | 0.89 | MAPT (1.00) | MAPTNQO2KMT2AMEN1NPC1 | |
| Benzo[B]Phenazine SCHEMBL5481172 | 0.87 | NQO2 (1.00) | MAPTNQO2KMT2AMEN1NPC1 | |
| SCHEMBL13156530 | 0.86 | NQO2 (0.59) | MAPTNQO2KMT2AMEN1NPC1 | |
| SCHEMBL31315039 | 0.86 | NQO2 (0.59) | MAPTNQO2KMT2AMEN1NPC1 | |
| SCHEMBL17652916 | 0.86 | NQO2 (0.68) | MAPTNQO2KMT2AMEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116355361-B | Organic semiconductor single crystal composite oriented polymer film, preparation method, photoelectric device and application | 浙江大学 | 2023-09-29 | — | — | CN | disclosed |
| US-20220146606-A1 | POLARIZATION SOURCE FOR DYNAMIC NUCLEAR POLARIZATION, COMPOSITION, COMPOSITION FOR DYNAMIC NUCLEAR POLARIZATION, METHOD FOR HYPERPOLARIZATION, HYPERPOLARIZED SUBSTANCE AND NMR MEASUREMENT METHOD | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| EP-3932911-A1 | POLARIZATION SOURCE FOR DYNAMIC NUCLEAR POLARIZATION, COMPOSITION, COMPOSITION FOR DYNAMIC NUCLEAR POLARIZATION, METHOD FOR HYPERPOLARIZATION, HYPERPOLARIZED SUBSTANCE AND NMR MEASUREMENT METHOD | Kyushu University, National University Corporation (JP) | 2022-01-05 | — | — | EP | disclosed |
| US-9120803-B2 | Processes for the preparation of sodium 5,14-dihydrotetraazapentacene polysulfonate, and intermediates thereof | SIGNA S.A. DE C.V. (MX) | 2015-09-01 | — | — | US | disclosed |
| US-20130331572-A1 | PROCESSES FOR THE PREPARATION OF SODIUM 5,14-DIHYDROTETRAAZAPENTACENE POLYSULFONATE, AND INTERMEDIATES THEREOF | SIGNA S.A. DE C.V. (MX) | 2013-12-12 | — | — | US | disclosed |
| US-7800103-B2 | Organic thin film transistor material, organic thin film transistor, field-effect transistor, switching element, organic semiconductor material and organic semiconductor film | KONICA MINOLTA HOLDINGS, INC. (JP) | 2010-09-21 | — | — | US | disclosed |
| US-7800103-B2 | Organic thin film transistor material, organic thin film transistor, field-effect transistor, switching element, organic semiconductor material and organic semiconductor film | KONICA MINOLTA HOLDINGS, INC. (JP) | 2010-09-21 | — | — | US | disclosed |
| US-20080121873-A1 | Organic Thin Film Transistor Material, Organic Thin Film Transistor, Field-Effect Transistor, Switching Element, Organic Semiconductor Material and Organic Semiconductor Film | KONICA MINOLTA HOLDINGS, INC. (JP) | 2008-05-29 | — | — | US | disclosed |
| US-20080121873-A1 | Organic Thin Film Transistor Material, Organic Thin Film Transistor, Field-Effect Transistor, Switching Element, Organic Semiconductor Material and Organic Semiconductor Film | KONICA MINOLTA HOLDINGS, INC. (JP) | 2008-05-29 | — | — | US | disclosed |
| EP-1552813-B1 | Hair dyeing composition comprising a fluorindinium compound. | OREAL (FR) | 2008-03-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220146606-A1 | POLARIZATION SOURCE FOR DYNAMIC NUCLEAR POLARIZATION, COMPOSITION, COMPOSITION FOR DYNAMIC NUCLEAR POLARIZATION, METHOD FOR HYPERPOLARIZATION, HYPERPOLARIZED SUBSTANCE AND NMR MEASUREMENT METHOD | H1-10, ZYX, HNRNPR | MAPT 2217/4885NQO2 1580/4885KMT2A 3315/4885 |
| US-20130331572-A1 | PROCESSES FOR THE PREPARATION OF SODIUM 5,14-DIHYDROTETRAAZAPENTACENE POLYSULFONATE, AND INTERMEDIATES THEREOF | DHPS, STS, MPST | MAPT 4202/4885NQO2 951/4885KMT2A 2684/4885 |
| US-20080121873-A1 | Organic Thin Film Transistor Material, Organic Thin Film Transistor, Field-Effect Transistor, Switching Element, Organic Semiconductor Material and Organic Semiconductor Film | TERT, TELO2, RCOR1 | MAPT 433/4885NQO2 2650/4885KMT2A 1347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.